135 related articles for article (PubMed ID: 36813059)
1. Structural analysis and conformational dynamics of SOCS1 gene mutations involved in diffuse large B-cell lymphoma.
Dristy TT; Noor AR; Dey P; Saha A
Gene; 2023 May; 864():147293. PubMed ID: 36813059
[TBL] [Abstract][Full Text] [Related]
2. SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.
Schif B; Lennerz JK; Kohler CW; Bentink S; Kreuz M; Melzner I; Ritz O; Trümper L; Loeffler M; Spang R; Möller P
Oncotarget; 2013 Jan; 4(1):35-47. PubMed ID: 23296022
[TBL] [Abstract][Full Text] [Related]
3. The impact of SOCS1 mutations in diffuse large B-cell lymphoma.
Mellert K; Martin M; Lennerz JK; Lüdeke M; Staiger AM; Kreuz M; Löffler M; Schmitz N; Trümper L; Feller AC; Hartmann S; Hansmann ML; Klapper W; Stein H; Rosenwald A; Ott G; Ziepert M; Möller P
Br J Haematol; 2019 Dec; 187(5):627-637. PubMed ID: 31407320
[TBL] [Abstract][Full Text] [Related]
4. Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
Juskevicius D; Jucker D; Klingbiel D; Mamot C; Dirnhofer S; Tzankov A
J Hematol Oncol; 2017 Mar; 10(1):70. PubMed ID: 28302137
[TBL] [Abstract][Full Text] [Related]
5. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.
Mottok A; Renné C; Seifert M; Oppermann E; Bechstein W; Hansmann ML; Küppers R; Bräuninger A
Blood; 2009 Nov; 114(20):4503-6. PubMed ID: 19734449
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
Lennerz JK; Hoffmann K; Bubolz AM; Lessel D; Welke C; Rüther N; Viardot A; Möller P
Oncotarget; 2015 Oct; 6(30):29097-110. PubMed ID: 26336985
[TBL] [Abstract][Full Text] [Related]
7. Computational analysis of structural and functional evaluation of the deleterious missense variants in the human
Bouqdayr M; Abbad A; Baba H; Saih A; Wakrim L; Kettani A
J Biomol Struct Dyn; 2023; 41(23):14179-14196. PubMed ID: 36764830
[TBL] [Abstract][Full Text] [Related]
8. A computational in silico approach to predict high-risk coding and non-coding SNPs of human PLCG1 gene.
Khan SM; Faisal AM; Nila TA; Binti NN; Hosen MI; Shekhar HU
PLoS One; 2021; 16(11):e0260054. PubMed ID: 34793541
[TBL] [Abstract][Full Text] [Related]
9. Evolution- and structure-based computational strategy reveals the impact of deleterious missense mutations on MODY 2 (maturity-onset diabetes of the young, type 2).
George DC; Chakraborty C; Haneef SA; Nagasundaram N; Chen L; Zhu H
Theranostics; 2014; 4(4):366-85. PubMed ID: 24578721
[TBL] [Abstract][Full Text] [Related]
10.
Schuhmacher B; Bein J; Rausch T; Benes V; Tousseyn T; Vornanen M; Ponzoni M; Thurner L; Gascoyne R; Steidl C; Küppers R; Hansmann ML; Hartmann S
Haematologica; 2019 Feb; 104(2):330-337. PubMed ID: 30213827
[TBL] [Abstract][Full Text] [Related]
11. Functional and Structural Consequences of Damaging Single Nucleotide Polymorphisms in Human Prostate Cancer Predisposition Gene RNASEL.
Datta A; Mazumder MH; Chowdhury AS; Hasan MA
Biomed Res Int; 2015; 2015():271458. PubMed ID: 26236721
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics simulations and bioinformatics' analysis of deleterious missense single nucleotide polymorphisms in Glyoxalase-1 gene.
Syed NA; Bhatti A; John P
J Biomol Struct Dyn; 2023; 41(23):13707-13717. PubMed ID: 36812296
[TBL] [Abstract][Full Text] [Related]
13. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
[TBL] [Abstract][Full Text] [Related]
14. Combination of two monoclonal antibodies with SOCS1 N- and C-terminal binding sites to address SOCS1 status in B cells and B-cell lymphoma.
Weissinger SE; Zahn M; Marienfeld R; Tessmer C; Moldenhauer G; Möller P
Eur J Haematol; 2022 Mar; 108(3):223-231. PubMed ID: 34854137
[TBL] [Abstract][Full Text] [Related]
15. FAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphoma.
Wohlfart S; Sebinger D; Gruber P; Buch J; Polgar D; Krupitza G; Rosner M; Hengstschläger M; Raderer M; Chott A; Müllauer L
Am J Pathol; 2004 Mar; 164(3):1081-9. PubMed ID: 14982861
[TBL] [Abstract][Full Text] [Related]
16. [SOCSJ gene mutations in patients with diffuse large B-cell lymphoma].
Gavrilina OA; Zvonkov EE; Biderman BV; Severina NA; Parovichnikova EN
Ter Arkh; 2015; 87(7):105-111. PubMed ID: 26390734
[TBL] [Abstract][Full Text] [Related]
17. Estimation of varicocele associated human ARG2 and NOS1 proteins and computational analysis on the effect of its nsSNPs.
Karthikeyan V; Vickram AS; Manian R
Int J Biol Macromol; 2020 Dec; 164():735-747. PubMed ID: 32693129
[TBL] [Abstract][Full Text] [Related]
18. Screening of high-risk deleterious missense variations in the
Shahid M; Azfaralariff A; Tufail M; Hussain Khan N; Abdulkareem Najm A; Firasat S; Zubair M; Fazry S; Law D
PeerJ; 2022; 10():e14132. PubMed ID: 36518267
[TBL] [Abstract][Full Text] [Related]
19. Predicting the functional and structural consequences of nsSNPs in human methionine synthase gene using computational tools.
Desai M; Chauhan JB
Syst Biol Reprod Med; 2019 Aug; 65(4):288-300. PubMed ID: 30676783
[TBL] [Abstract][Full Text] [Related]
20. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.
Hirschfield GM; Xie G; Lu E; Sun Y; Juran BD; Chellappa V; Coltescu C; Mason AL; Milkiewicz P; Myers RP; Odin JA; Luketic VA; Bacon B; Bodenheimer H; Liakina V; Vincent C; Levy C; Pillai S; Lazaridis KN; Amos CI; Siminovitch KA
Genes Immun; 2012 Jun; 13(4):328-35. PubMed ID: 22257840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
